NCT07840911

Brief Summary

Furlow with buccal myomucosal flap (group 1) Local anesthesia with a vasoconstrictor will be injected at the beginning of the surgery after Z- flap outline marking. On the left side, myomucosal posteriorly based flap will be incised containing the levator palateni muscle with a 60◦ angle and elevated. Another small anteriorly-based nasal mucosa flap will be created. On the opposite side, oral mucosal anteriorly based flap with a 90◦ angle will be incised and elevated. Palatal muscle will be stripped and posteriorly based myomucosal flap was created containing palatal muscle and nasal mucosa. Nasal mucosa will be sutured followed by oral mucosa with minimal palatal muscle overlapping. The oral mucosa defect will be filled with BMMF Two flap palatoplasty surgical steps (group 2) A bilateral tongue like palatal flaps will be incised and elevated from the incisive foramen anteriorly to the hamulus posteriorly medial to the teeth and extended around the cleft area. Palatal muscles will be detached from the palatal shelves and separating it from the nsal mucosa. Nasal layer will be the firstly closed, followed by the muscle and oral mucosal layers. In case of the presence of a bare area of bone, it will be left to heal by secondary intention

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
12mo left

Started Sep 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
Sep 2026Sep 2027

First Submitted

Initial submission to the registry

September 15, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 25, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

September 25, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2027

Expected
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2027

Last Updated

September 25, 2026

Status Verified

September 1, 2026

Enrollment Period

11 months

First QC Date

September 15, 2026

Last Update Submit

September 19, 2026

Conditions

Keywords

cleft palatefistula

Outcome Measures

Primary Outcomes (1)

  • fistula formation

    assessment the fistula formation after cleft palate repair by determination the site of fistula and time at which appear

    6 months postoperative

Study Arms (2)

furlow with buccinator

EXPERIMENTAL
Procedure: furlow with buccinator

two flap palatoplasty

ACTIVE COMPARATOR
Procedure: two flap palatoplasty

Interventions

clefted patients were treated with furlow with buccinator flap

furlow with buccinator

clefted patients were treated with two flap palatoplasty

two flap palatoplasty

Eligibility Criteria

Age9 Months - 12 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • months old childreen with complete cleft lip and palate, nonsyndromic.
  • lip and palate repair performed by one craniofacial surgeon

You may not qualify if:

  • Patients with syndromic cleft lip.
  • Redu cases
  • Bilateral cleft lip
  • Associated Cardiac anomalies.
  • Any systemic condition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Cleft PalateFistula

Condition Hierarchy (Ancestors)

Jaw AbnormalitiesJaw DiseasesMusculoskeletal DiseasesMaxillofacial AbnormalitiesCraniofacial AbnormalitiesMusculoskeletal AbnormalitiesStomatognathic DiseasesMouth AbnormalitiesMouth DiseasesStomatognathic System AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Central Study Contacts

Shaimaa Refahee

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor

Study Record Dates

First Submitted

September 15, 2026

First Posted

September 25, 2026

Study Start

September 25, 2026

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

September 30, 2027

Last Updated

September 25, 2026

Record last verified: 2026-09